Patients were excluded if they had any other chronic liver disease other than MASLD/MASH including alcohol, viral, drug-induced, autoimmune, Budd-Chiari syndrome, Wilsons disease, alpha-1-antitrypsin deficiency, hereditary hemochromatosis, primary/secondary biliary cholangitis, primary sclerosing cholangitis, liver disorders in diseases classified elsewhere, and other chronic hepatitis not classified elsewhere
Eli Lillys pending approval, combined with emerging nextgeneration incretin candidates, ensures that the race for leadership in obesity care is far from settled
This article examines the evidence, distinguishes benign causes from serious gastrointestinal bleeding, and provides guidance on managing digestive symptoms whilst taking Ozempic
GLP-1: slows stomach emptying, reduces glucagon and increases satiety (fullness)
Patients with insulin resistance who tolerate Zepbound well may discuss adding berberine under supervision
To perform a patch test, apply a small amount of the product to the inside of your elbow and wait 24 hours
